Deciphering the Molecular Crosstalk of Endoplasmic Reticulum Stress and Immune Infiltration in Endometriosis
American Journal of Reproductive Immunology · 2025-05 · 93 (5)
DOI: 10.1111/aji.70092 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, online erschienen am 15.05.2025. Verfasst von Yuan Ma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Ningxia Medical University, Yinchuan, China. Hauptthemen laut MEDLINE: Endoplasmic Reticulum Stress, Endometriosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Ningxia Natural Science Foundation, Natural Science Foundation of Ningxia Province.
Abstract (Originalsprache)
Background
Endometriosis (EMs), characterized by ectopic endometrial growth causing infertility. Endoplasmic reticulum stress (ERS) is an important cellular defense mechanism. However, the correlation between ERS and EMs remains unclear. We aimed to investigate the relationship between them, identify biomarkers, and offer new insights into the treatment of EMs.
Methods
Two RNA expression datasets (GSE120103 and GSE25628) related to EMs in Homo sapiens were used to identify ERS‐differentially expressed genes (ERS‐DEGs). Protein–protein interaction (PPI) networks and CytoHubba (Cytoscape) identified ERS‐associated HUB genes, with receiver operating characteristic curves (ROC) evaluating diagnostic value. Constructed mRNA‐microRNA (miRNA)/RNA‐transcription factor (TF) interaction networks and performed ssGSEA to compare immune infiltration between EMs patients and controls. Real‐time quantitative polymerase chain reaction (RT‐qPCR), western blotting (WB), and immunohistochemistry (IHC) were performed to assess potential biomarker levels.
Results
Thirty‐three ERS‐DEGs were identified, with nine HUB genes ( HSPA5, XBP1, HSP90B1, DNAJC3, PDIA3, PDIA6, PDIA4, HERPUD1 , and MANF ) demonstrating diagnostic efficacy (AUC > 0.7). Furthermore, immune infiltration revealed a significant relationship between immune cell abundance and HUB gene expression. Experimental validation confirmed the consistency of four biomarkers ( HSPA5, HSP90B1, PDIA6 , and HERPUD1 ). Regulatory network analysis identified 62 miRNAs and 44 TFs interacting with HUB genes, suggesting a multifactorial immunometabolic axis.
Conclusions
We identified four biomarkers ( HSPA5, HSP90B1, PDIA6 , and HERPUD1 ) associated with ERS that offer new insights into the detection and treatment of EMs. Our findings indicate an abnormal response to ERS and immune system infiltration contribute to the progression of EMs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ningxia Medical University, Yinchuan, China.
- General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
- Key Laboratory of Fertility Preservation & Maintenance of Ministry of Education, Ningxia Medical University, Yinchuan, Ningxia, China.
ORCID-Profile: Yuan Ma
Förderung
- National Natural Science Foundation of China
- Ningxia Natural Science Foundation
- Natural Science Foundation of Ningxia Province
Zitieren
APA
Ma, Y., Ha, C., Li, R., Zhang, R., & Li, M. (2025). Deciphering the Molecular Crosstalk of Endoplasmic Reticulum Stress and Immune Infiltration in Endometriosis. American Journal of Reproductive Immunology, 93(5). https://doi.org/10.1111/aji.70092
Vancouver
Ma Y, Ha C, Li R, Zhang R, Li M. Deciphering the Molecular Crosstalk of Endoplasmic Reticulum Stress and Immune Infiltration in Endometriosis. American Journal of Reproductive Immunology. 2025;93(5). doi:10.1111/aji.70092
BibTeX
@article{Ma2025,
author = {Ma, Yuan and Ha, Chunfang and Li, Ruyue and Zhang, Ruiqi and Li, Min},
title = {Deciphering the Molecular Crosstalk of Endoplasmic Reticulum Stress and Immune Infiltration in Endometriosis},
journal = {American Journal of Reproductive Immunology},
year = {2025},
volume = {93},
number = {5},
doi = {10.1111/aji.70092}
}
EUVIMED